Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases

Journal of Neuro-Oncology(2022)10.1007/s11060-022-03949-1Source: DataRank Database

Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases is a research paper published in Journal of Neuro-Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 43 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access43 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 5.07)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Priya Singh ORCID,Ivan S. Kotchetkov ORCID,Anna Skakodub ORCID,Alicia Meng ORCID,Christel Tamer

Live enrichment

PubMed:35113288 PMC:PMC9119011 OpenAlex:https://openalex.org/W4220862816

National Institutes of Health

Grant: P30-CA008748

NCI NIH HHS

Grant: P30 CA008748

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

FWCI

5.07

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: CC BY

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9119011

publisherhttps://link.springer.com/content/pdf/10.1007/s11060-022-03949-1.pdf

publisherhttps://link.springer.com/article/10.1007/s11060-022-03949-1/fulltext.html

journalhttps://doi.org/10.1007/s11060-022-03949-1

Fields of Study

Brain Metastases and TreatmentGlioma Diagnosis and TreatmentLung Cancer Research Studies0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

Cell CountHumansNeoplastic Cells, CirculatingPrognosisRetrospective StudiesBiomarkers, TumorMeningeal Carcinomatosis

Keywords

MedicineCerebrospinal fluidInternal medicineProportional hazards modelRetrospective cohort studyCirculating tumor cellNeuroimagingOncologyCohortCytologySurvival analysisPathologyRadiologyGastroenterologyCancerMetastasisBiomarkerBrain metastasesCirculating Tumor CellsLeptomeningeal MetastasesBiomarkers, TumorHumansCell CountNeoplastic Cells, CirculatingPrognosisMeningeal CarcinomatosisRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (1)

Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

N/A

1.9DataRank · unranked

Journal of Neuro-Oncology(2020)

co-citedsame journal

10.1007/s11060-020-03555-z

Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases

FAIR Checklist

Authors (11)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)

Related Papers (1)